ZA9610511B - Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents. - Google Patents

Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents.

Info

Publication number
ZA9610511B
ZA9610511B ZA9610511A ZA9610511A ZA9610511B ZA 9610511 B ZA9610511 B ZA 9610511B ZA 9610511 A ZA9610511 A ZA 9610511A ZA 9610511 A ZA9610511 A ZA 9610511A ZA 9610511 B ZA9610511 B ZA 9610511B
Authority
ZA
South Africa
Prior art keywords
production
well
pharmaceutical agents
acid conjugates
phosphonocarboxylic acid
Prior art date
Application number
ZA9610511A
Other languages
English (en)
Inventor
Harald Zilch
Dieter Herrmann
Hans-Georg Opitz
Gerd Zimmermann
Edgar Voss
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA9610511B publication Critical patent/ZA9610511B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9610511A 1995-12-15 1996-12-13 Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents. ZA9610511B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19547022A DE19547022A1 (de) 1995-12-15 1995-12-15 Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel

Publications (1)

Publication Number Publication Date
ZA9610511B true ZA9610511B (en) 1998-06-15

Family

ID=7780310

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610511A ZA9610511B (en) 1995-12-15 1996-12-13 Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents.

Country Status (25)

Country Link
US (1) US5955452A (cs)
EP (1) EP0869817B1 (cs)
JP (1) JP2000505784A (cs)
KR (1) KR20000064375A (cs)
CN (1) CN1209069A (cs)
AR (1) AR005065A1 (cs)
AT (1) ATE219379T1 (cs)
AU (1) AU714922B2 (cs)
BR (1) BR9612137A (cs)
CA (1) CA2240365A1 (cs)
CZ (1) CZ292531B6 (cs)
DE (2) DE19547022A1 (cs)
ES (1) ES2179222T3 (cs)
HU (1) HUP0001524A3 (cs)
IL (1) IL124789A (cs)
MX (1) MX9804752A (cs)
NO (1) NO982755L (cs)
NZ (1) NZ325260A (cs)
PL (1) PL185115B1 (cs)
RU (1) RU2178418C2 (cs)
SK (1) SK282035B6 (cs)
TR (1) TR199801083T2 (cs)
TW (1) TW409128B (cs)
WO (1) WO1997022368A2 (cs)
ZA (1) ZA9610511B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW343975B (en) * 1995-12-15 1998-11-01 Boehringer Mannheim Gmbh New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents
US6818057B2 (en) 1999-03-02 2004-11-16 Construction Research & Technology Gmbh Retarder for calcium sulfoaluminate cements
US20040172288A1 (en) * 2003-02-27 2004-09-02 Korn Lawrence D. Method for disseminating medical alert information
KR20110095288A (ko) * 2008-11-06 2011-08-24 바스큘라 바이오제닉스 리미티드 산화된 지질 화합물 및 이의 용도
EP2876094A1 (en) 2014-04-03 2015-05-27 Basf Se Cement and calcium sulphate based binder composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150125A (en) * 1977-09-30 1979-04-17 Abbott Laboratories Triglyceride ester of phosphonoacetic acid having antiviral activity
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
JPH0421694A (ja) * 1990-05-16 1992-01-24 Asahi Chem Ind Co Ltd 新規なヌクレオシド―リン脂質複合体
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
IT1249063B (it) * 1991-05-28 1995-02-11 Fidia Spa Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
TW343975B (en) * 1995-12-15 1998-11-01 Boehringer Mannheim Gmbh New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents

Also Published As

Publication number Publication date
ATE219379T1 (de) 2002-07-15
HUP0001524A2 (hu) 2001-05-28
JP2000505784A (ja) 2000-05-16
AU714922B2 (en) 2000-01-13
PL185115B1 (pl) 2003-02-28
ES2179222T3 (es) 2003-01-16
KR20000064375A (ko) 2000-11-06
RU2178418C2 (ru) 2002-01-20
AU1373197A (en) 1997-07-14
SK75598A3 (en) 1999-04-13
AR005065A1 (es) 1999-04-07
CZ180998A3 (cs) 1998-09-16
EP0869817B1 (de) 2002-06-19
DE19547022A1 (de) 1997-06-19
MX9804752A (es) 1998-10-31
DE59609377D1 (de) 2002-07-25
SK282035B6 (sk) 2001-10-08
NO982755L (no) 1998-08-14
TW409128B (en) 2000-10-21
EP0869817A2 (de) 1998-10-14
PL327138A1 (en) 1998-11-23
HUP0001524A3 (en) 2001-05-28
WO1997022368A2 (de) 1997-06-26
US5955452A (en) 1999-09-21
NO982755D0 (no) 1998-06-15
IL124789A0 (en) 1999-01-26
NZ325260A (en) 1999-11-29
CA2240365A1 (en) 1997-06-26
CZ292531B6 (cs) 2003-10-15
IL124789A (en) 2002-03-10
TR199801083T2 (xx) 1998-10-21
CN1209069A (zh) 1999-02-24
BR9612137A (pt) 1999-07-13
WO1997022368A3 (de) 1997-10-23

Similar Documents

Publication Publication Date Title
ZA200108530B (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
HUP0003073A3 (en) Benzenesulfonamide derivatives, process for producing them and their use as medicines
ZA200201511B (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents.
MXPA02001497A (es) Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales.
HUP0200312A3 (en) Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use
HUP0004422A3 (en) 2-aryl-8-oxohydropurine derivatives, process for producing them, medicaments containing the same
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
ZA200104196B (en) Azepinoindole derivatives, the production and use thereof.
IS4309A (is) Nýjar erýþrómýsin afleiður, sem og læknislyf sem innihalda þær
ZA94335B (en) 2,6-Diaminopurine derivatives.
PL344467A1 (en) Substituted indolinones, the production thereof and their use as medicaments
ZA200202521B (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds.
HUP0203290A3 (en) Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
ZA9811506B (en) Novel pharmaceutical.
HUP9901376A3 (en) 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same
ZA961884B (en) Novel naphthyl pharmaceutical compounds.
IL134572A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6- methano-3-benzazocine-10-oles, methods for the production and use thereof as medicaments
ZA968134B (en) The production of vitamin-containing solid formulations.
HUP0203045A3 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
AU1373197A (en) Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents
EP0297594A3 (en) Novel 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives
EP0641776A3 (en) Thioglycerol derivatives.
ZA200110454B (en) Pharmaceutical complex.